| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Stoke Therapeutics, Inc. (STOK) | S | 605 | $36.80 | $22,264.00 | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 13,489 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 10,034 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 16,562 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 131,372 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 144,000 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 12,500 | - | - | View Details Filing |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | D | 115,500 | - | - | View Details Filing |
| Jan 21, 2026 | Avidity Biosciences, Inc. (RNAM) | S | 1,758 | $72.45 | $127,367.10 | View Details Filing |
| Dec 31, 2025 | Stoke Therapeutics, Inc. (STOK) | M | 1,211 | $0.00 | $0.00 | View Details Filing |
| Dec 31, 2025 | Stoke Therapeutics, Inc. (STOK) | M | 1,211 | $0.00 | $0.00 | View Details Filing |